Rotherham Doncaster and South Humber NHS Foundation Trust patient group director (PGD) for the supply of imiquimod 5% weight by weight cream for the treatment of external anogenital warts.
This patient group direction (PGD) must only be used by registered professionals who have been named and authorised by their organisation to practise under it.
This PGD template has been peer reviewed by the sexual health PGDs short life working group in accordance with their terms of reference. It has been approved by the British association for sexual health and HIV (BASHH) and bacterial special interest group (BSIG) in February 2021.
To access this PGD please follow the link: Sexual health Imiquimod national (staff access only) (opens in new window).
To access the equality impact assessment for this policy, please see the overarching equality impact assessment.
Page last reviewed: January 17, 2025
Next review due: January 17, 2026
Problem with this page?
Please tell us about any problems you have found with this web page.
Report a problem